UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis

Biomedicine & pharmacotherapy, 2022-10, Vol.154, p.113572, Article 113572

2022

Volltextzugriff (PDF)

Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway

Biomedicine & pharmacotherapy, 2021-01, Vol.133, p.110993-110993, Article 110993

2021

Volltextzugriff (PDF)

The role of microRNA in modulating myocardial ischemia-reperfusion injury

Physiological genomics, 2011-05, Vol.43 (10), p.534-542

2011

Volltextzugriff (PDF)

Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis

Biomedicine & pharmacotherapy, 2020-05, Vol.125, p.110001, Article 110001

2020

Volltextzugriff (PDF)

Dexmedetomidine preconditioning attenuates ischemia/reperfusion injury in isolated rat hearts with endothelial dysfunction

Biomedicine & pharmacotherapy, 2019-06, Vol.114, p.108837-108837, Article 108837

2019

Volltextzugriff (PDF)

Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome

BMJ open diabetes research & care, 2016-08, Vol.4 (1), p.e000227-e000227

2016

Volltextzugriff (PDF)

Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis

Biomedicine & pharmacotherapy, 2023-09, Vol.165, p.115255-115255, Article 115255

2023

Volltextzugriff (PDF)

Dexmedetomidine alleviates H2O2-induced oxidative stress and cell necroptosis through activating of α2-adrenoceptor in H9C2 cells

Molecular biology reports, 2020-05, Vol.47 (5), p.3629-3639

2020

Volltextzugriff (PDF)

Oxytocin ameliorates high glucose- and ischemia/reperfusion-induced myocardial injury by suppressing pyroptosis via AMPK signaling pathway

Biomedicine & pharmacotherapy, 2022-09, Vol.153, p.113498-113498, Article 113498

2022

Volltextzugriff (PDF)

Dexmedetomidine preconditioning mitigates myocardial ischemia/reperfusion injury via inhibition of mast cell degranulation

Biomedicine & pharmacotherapy, 2021-09, Vol.141, p.111853-111853, Article 111853

2021

Volltextzugriff (PDF)

Involvement of miR-665 in protection effect of dexmedetomidine against Oxidative Stress Injury in myocardial cells via CB2 and CK1

Biomedicine & pharmacotherapy, 2019-07, Vol.115, p.108894-108894, Article 108894

2019

Volltextzugriff (PDF)

The administration of dexmedetomidine changes microRNA expression profiling of rat hearts

Biomedicine & pharmacotherapy, 2019-12, Vol.120, p.109463-109463, Article 109463

2019

Volltextzugriff (PDF)

Oxytocin ameliorates ischemia/reperfusion-induced injury by inhibiting mast cell degranulation and inflammation in the rat heart

Biomedicine & pharmacotherapy, 2020-08, Vol.128, p.110358-110358, Article 110358

2020

Volltextzugriff (PDF)

Effect of miR-23 on oxidant-induced injury in human retinal pigment epithelial cells

Investigative ophthalmology & visual science, 2011-08, Vol.52 (9), p.6308

2011

Volltextzugriff (PDF)

Corrigendum to “Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis” [Biomed. Pharmacother. 125 (2020) 110001]

Biomedicine & pharmacotherapy, 2020-10, Vol.130, p.110841-110841, Article 110841

2020

Volltextzugriff (PDF)

Circulating miRNA Expression Profiling and Target Prediction in Patients Receiving Dexmedetomidine

Cellular physiology and biochemistry, 2018-01, Vol.50 (2), p.552-568

2018

Volltextzugriff (PDF)

Oxytocin Protects Against Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting PI3K/AKT Pathway via a lncRNA GAS5/miR-375-3p/KLF4-Dependent Mechanism

Frontiers in pharmacology, 2021-12, Vol.12, p.766024-766024

2021

Volltextzugriff (PDF)

Expression Profiling of Circular RNAs and Micrornas in Heart Tissue of Mice with Alcoholic Cardiomyopathy

Cellular physiology and biochemistry, 2018-01, Vol.46 (6), p.2284-2296

2018

Volltextzugriff (PDF)

Nebivolol Induces Distinct Changes in Profibrosis MicroRNA Expression Compared With Atenolol, in Salt-Sensitive Hypertensive Rats

Hypertension (Dallas, Tex. 1979), 2013-05, Vol.61 (5), p.1008-1013

2013

Volltextzugriff (PDF)

Impact of HMG-CoA reductase inhibition on oxidant-induced injury in human retinal pigment epithelium cells

Journal of cellular biochemistry, 2011-09, Vol.112 (9), p.2480-2489

2011

Volltextzugriff (PDF)

Phosphodiesterase III Inhibition Increases cAMP Levels and Augments the Infarct Size Limiting Effect of a DPP-4 Inhibitor in Mice with Type-2 Diabetes Mellitus

Cardiovascular drugs and therapy, 2012-12, Vol.26 (6), p.445-456

2012

Volltextzugriff (PDF)

Aliskiren and Valsartan Reduce Myocardial AT1 Receptor Expression and Limit Myocardial Infarct Size in Diabetic Mice

Cardiovascular drugs and therapy, 2011-12, Vol.25 (6), p.505-515

2011

Volltextzugriff (PDF)

Dipyridamole with Low-Dose Aspirin Augments the Infarct Size-Limiting Effects of Simvastatin

Cardiovascular drugs and therapy, 2010-12, Vol.24 (5-6), p.391-399

2010

Volltextzugriff (PDF)

Insight into long noncoding RNA–miRNA–mRNA axes in myocardial ischemia-reperfusion injury: the implications for mechanism and therapy

Epigenomics, 2019-11, Vol.11 (15), p.1733-1748

2019

Volltextzugriff (PDF)

Insight into Cardioprotective Effects and Mechanisms of Dexmedetomidine

Cardiovascular drugs and therapy, 2024-06

2024

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Englisch
(69)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(37)
Animals
(23)
Pharmacology & Pharmacy
(17)
Male
(14)
Humans
(11)
Physical Sciences
(11)
Dexmedetomidine
(10)
Myocardial Reperfusion Injury - Metabolism
(10)
Apoptosis
(9)
Apoptosis - Drug Effects
(9)
Cardiovascular System & Cardiology
(9)
Medicine, Research & Experimental
(9)
Mice
(9)
Micrornas - Genetics
(9)
Rats
(9)
Research & Experimental Medicine
(9)
Technology
(9)
Cardiac & Cardiovascular Systems
(8)
Chemistry
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis

Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway

The role of microRNA in modulating myocardial ischemia-reperfusion injury

Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis

Dexmedetomidine preconditioning attenuates ischemia/reperfusion injury in isolated rat hearts with endothelial dysfunction

Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome

Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis

Dexmedetomidine alleviates H2O2-induced oxidative stress and cell necroptosis through activating of α2-adrenoceptor in H9C2 cells

Oxytocin ameliorates high glucose- and ischemia/reperfusion-induced myocardial injury by suppressing pyroptosis via AMPK signaling pathway

Dexmedetomidine preconditioning mitigates myocardial ischemia/reperfusion injury via inhibition of mast cell degranulation

Involvement of miR-665 in protection effect of dexmedetomidine against Oxidative Stress Injury in myocardial cells via CB2 and CK1

The administration of dexmedetomidine changes microRNA expression profiling of rat hearts

Oxytocin ameliorates ischemia/reperfusion-induced injury by inhibiting mast cell degranulation and inflammation in the rat heart

Effect of miR-23 on oxidant-induced injury in human retinal pigment epithelial cells

Corrigendum to “Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis” [Biomed. Pharmacother. 125 (2020) 110001]

Circulating miRNA Expression Profiling and Target Prediction in Patients Receiving Dexmedetomidine

Oxytocin Protects Against Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting PI3K/AKT Pathway via a lncRNA GAS5/miR-375-3p/KLF4-Dependent Mechanism

Expression Profiling of Circular RNAs and Micrornas in Heart Tissue of Mice with Alcoholic Cardiomyopathy

Nebivolol Induces Distinct Changes in Profibrosis MicroRNA Expression Compared With Atenolol, in Salt-Sensitive Hypertensive Rats

Impact of HMG-CoA reductase inhibition on oxidant-induced injury in human retinal pigment epithelium cells

Phosphodiesterase III Inhibition Increases cAMP Levels and Augments the Infarct Size Limiting Effect of a DPP-4 Inhibitor in Mice with Type-2 Diabetes Mellitus

Aliskiren and Valsartan Reduce Myocardial AT1 Receptor Expression and Limit Myocardial Infarct Size in Diabetic Mice

Dipyridamole with Low-Dose Aspirin Augments the Infarct Size-Limiting Effects of Simvastatin

Insight into long noncoding RNA–miRNA–mRNA axes in myocardial ischemia-reperfusion injury: the implications for mechanism and therapy

Insight into Cardioprotective Effects and Mechanisms of Dexmedetomidine

Suchergebnisse filtern